Status:
UNKNOWN
Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers
Lead Sponsor:
Hospital Italiano de Buenos Aires
Collaborating Sponsors:
Roche Pharma AG
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will follow a single prospective cohort of 50 Health Care Workers in the Hospital Italiano de Buenos Aires (Argentina) from May 15th to August 31st 2020 using antibody testing for SA...
Detailed Description
SARS-CoV-2 infection in healthcare workers (HCW) is nowadays a frequent problem for patient care and organization of care teams. SARS-CoV-2 antibody assessment provides a tool to evaluate antibody pre...
Eligibility Criteria
Inclusion
- Healthcare staff (Physicians) AND
- Directly involved in care of patients with confirmed or suspected COVID-19 AND
- Working in any of the two hospital venues (Hospital Italiano Central and Hospital Italiano San Justo Agustín Rocca).
Exclusion
- Refusal to sign the Informed Consent Form OR
- Experienced symptoms compatible with COVID-19 in the last 14 days prior to eligibility screening
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04387890
Start Date
June 1 2020
End Date
August 31 2020
Last Update
May 28 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.